New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 12, 2012
16:37 EDTWXWuXi PharmaTech narrows FY12 revenue view to $495M-$498M from $488M-$498M
FY12 consensus $496.85M. Sees FY12 operating margin of about 17.5% on a GAAP basis and about 20.5% on a non-GAAP basis, compared to previous guidance of 17%-18.0% and 20.0%-21.0%, respectively.
News For WX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 21, 2014
05:33 EDTWXWuXi PharmaTech downgraded to Hold from Buy at Jefferies
Jefferies downgraded WuXi PharmaTech to Hold with a $38 price target saying upcoming margin pressure is not priced into shares or reflected in consensus estimates.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use